Beyond Air, Inc.
Market Cap
$4.08M
P/E Ratio
-0.18
EPS
$-4.47
Dividend Yield
0.00%
52-Week Range
$0.67 — $6.40
Volume
148.83K
Avg Volume
7.79M
Beta
0.42
P/E (TTM)
-0.18
Forward P/E
—
PEG Ratio
-0.01
P/S (TTM)
0.60
P/B (TTM)
0.87
P/FCF
—
EV/EBITDA
—
EV/Sales
—
ROE (TTM)
-2.80%
ROA (TTM)
-0.84%
ROIC
—
Gross Margin
0.02%
Operating Margin
-4.20%
Net Margin
—
Debt/Equity
3.06
Current Ratio
5.12
EPS Growth (YoY)
—
Revenue Growth (YoY)
—
EPS Growth (3Y)
+0.18%
EPS Growth (5Y)
+0.10%
Sales Growth (3Y)
+0.73%
Sales Growth (5Y)
+0.16%
EPS Est (This Year)
$-3.84
EPS Est (Next Year)
$-2.06
Dividend Yield
—
Annual Dividend
—
Payout Ratio
—
Frequency
—
Ex-Dividend Date
—
Cash/Share
$2.07
Institutional %
—
Inst. Net Change
—
Insider Net Shares (90d)
0
Outstanding Shares
5.07M
Float
4.78M
Free Float %
94.23%
Sector
Healthcare
Industry
Medical - Devices
Country
US
Exchange
NASDAQ
IPO Date
2018-06-12
Employees
107
CEO
Steven Adam Lisi
Index Membership
—
Website
https://www.beyondair.net
Beyond Air, Inc. (XAIR) is a healthcare company in the medical - devices industry listed on the NASDAQ. With a market capitalization of $4.08M, a P/E ratio of -0.18, XAIR is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare XAIR against other stocks using dozens of fundamental and technical filters.
Beyond Air, Inc. (XAIR) has a trailing twelve-month (TTM) P/E ratio of -0.18. This is below the market average, which may suggest the stock is undervalued or has lower growth expectations. The P/E ratio measures how much investors are willing to pay per dollar of earnings.
No, Beyond Air, Inc. (XAIR) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.
Beyond Air, Inc. (XAIR) has a market capitalization of $4.08 million, classifying it as a micro-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.